Loading...

22nd Century Group, Inc.

XXIINASDAQ
Consumer DefensiveTobacco
$1.15
$0.01(0.87%)

22nd Century Group, Inc. (XXII) Stock Overview

Explore 22nd Century Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-63.12%
63.12%
Profit Growth
$-7.95
89.23%
EPS Growth
$-7.95
49.37%
Operating Margin
-55.72%
68.95%
ROE
-541.78%
89.23%
Dividend Yield
0.00%
Analyst Recommendations data is not available for XXIIAnalyst Recommendations details for XXII are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

CEO

Mr. Lawrence D. Firestone

Employees

56

Headquarters

500 Seneca Street, Buffalo, NY

Founded

2011

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.